Who is more likely to get long COVID? New study uncovers genetic drivers behind the disease

Australian scientists have identified the key genetic drivers behind long COVID, revealing why some people continue to ...

Caris Life Sciences Announces Collaboration with Genentech to Discover Novel Therapeutic Targets in Cancers with High Unmet Clinical Need

Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine ...
Medscape

How a Rural Community Helped Uncover Allergy Defenses

The 1995 discovery of regulatory T cells underpins newer investigations pointing to potential allergy treatments and ...
PharmiWeb

Research Antibodies and Reagents Market Expected to Boost Moderately over 2030

Global Research Antibodies and Reagents Market OverviewThe global research antibodies and reagents market is expected to expand at a CAGR of 7% between 2025 and 2030, driven by the rising need for ...
Earth.com

Why long COVID won’t let go: Scientists uncover its genetic roots

Scientists reveal reasons why long COVID lasts, using global data to explain symptoms, risks, and how future treatment could ...
University at Buffalo

Balu-Iyer named fellow of National Academy of Inventors

The UB pharmacy professor’s research contributions and his numerous patents led to his inclusion in the prestigious ...
eLife

Multi-gradient permutation survival analysis identifies mitosis and immune signatures steadily associated with cancer patient prognosis

Genes steadily associated with prognosis define conserved mitotic and immune programs that robustly predict cancer patient survival and therapeutic resistance across tumor types.
BioProcess International

Cell-Line Development Is Critical to the Future of Complex Therapeutics

Cell-line development enhances biopharmaceutical production capacity and quality, but complex biologics like bsAbs and ADCs ...